Literature DB >> 10735674

Simultaneous carotid endarterectomy and coronary revascularization.

L Khaitan1, F P Sutter, S M Goldman, T Chamogeorgakis, M A Wertan, B P Priest, J D Whitlark.   

Abstract

BACKGROUND: Combined cardiac operation and carotid endarterectomy using our technique is an acceptable approach to simultaneous correction of both carotid and cardiac disease.
METHODS: From August 1989 to March 1998, 121 consecutive patients underwent combined operations. Of these patients, 112 had coronary artery bypass grafting and carotid endarterectomy, and 9 had coronary artery bypass grafting, carotid endarterectomy, and valve repair or replacement. All patients had a critical stenosis of 85% or more of the carotid artery. Mean age of the patients was 69.2 years; 80 patients were 65 years old or older. There were 88 men and 33 women. Notable risk factors included chronic obstructive pulmonary disease (19.8%), congestive heart failure (28%), preoperative myocardial infarction and unstable angina (66.9%). Of the patients, 20.7% had a stenosis of greater than 50% of the left main coronary artery. The technique used was correction of both the carotid and coronary lesions during a single aortic cross-clamp period using retrograde continuous blood cardioplegia for myocardial protection. Systemic hypothermia to 25 degrees C was used for cerebral protection.
RESULTS: Mean cross-clamp time was 118 minutes. Seven patients (5.8%) sustained perioperative cerebrovascular accidents. Two patients had transient ischemic attacks. The procedure-related mortality rate was 5.8%.
CONCLUSIONS: The described technique is a good method for simultaneous repair of coronary and carotid lesions in a high-risk group of patients with concomitant disease. We will continue to use it.

Entities:  

Mesh:

Year:  2000        PMID: 10735674     DOI: 10.1016/s0003-4975(99)01288-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Staged carotid endarterectomy under local anaesthetic in patients requiring cardiac surgery.

Authors:  David Birchley; Jaime Villaquiran; Enoch Akowuah; Terence Lewis; Simon Ashley
Journal:  Ann R Coll Surg Engl       Date:  2010-04-09       Impact factor: 1.891

Review 2.  Contemporary Management of Patients with Concomitant Coronary and Carotid Artery Disease.

Authors:  Mun J Poi; Angela Echeverria; Peter H Lin
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

3.  A single-stage procedure for carotid endarterectomy and myocardial revascularization: early and late results.

Authors:  Luigi Di Tommaso; Gabriele Iannelli; Mario Monaco; Michele Mottola; Vincenzo De Amicis; Nicola Spampinato
Journal:  Tex Heart Inst J       Date:  2005

4.  The role of combined carotid endarterectomy and coronary artery bypass grafting in the era of carotid stenting in view of long-term results.

Authors:  Eli Levy; Dimtry Yakubovitch; Ehud Rudis; Haim Anner; Giora Landsberg; Yaakov Berlatzky; Amir Elami
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-09-11

5.  Prevalence of concomitant atherosclerotic arterial diseases in patients with significant cervical carotid artery stenosis in Taiwan.

Authors:  Yen-Wen Wu; Mao-Shin Lin; Yen-Hung Lin; Chia-Lun Chao; Hsien-Li Kao
Journal:  Int J Cardiovasc Imaging       Date:  2006-11-22       Impact factor: 2.316

6.  Comparison of Early Outcomes with Three Approaches for Combined Coronary Revascularization and Carotid Endarterectomy.

Authors:  Arzu Antal Dönmez; Taylan Adademir; Hakan Sacli; Cengiz Koksal; Mete Alp
Journal:  Braz J Cardiovasc Surg       Date:  2016 Sep-Oct

7.  Early results of combined and staged coronary bypass and carotid endarterectomy in advanced age patients in single centre.

Authors:  Hikmet Iyem; Suat Buket
Journal:  Open Cardiovasc Med J       Date:  2009-03-20

8.  Simultaneous coronary artery bypass grafting and carotid endarterectomy can be performed with low mortality rates.

Authors:  Ebuzer Aydin; Yucel Ozen; Sabit Sarikaya; Ismail Yukseltan
Journal:  Cardiovasc J Afr       Date:  2014 May-Jun       Impact factor: 1.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.